Pooled safety analysis in patients with visual impairment due to diabetic macular edema treated with 0.5 mg ranibizumab in RESOLVE and RESTORE trials

被引：0
|
作者：
Bandello, F. [1 ]
Lang, G. E. [2 ]
Schlingemann, R. O. [3 ]
Leclair, D. [4 ]
Weichselberger, A. [5 ]
机构：
[1] Univ Vita Salute Sci Inst, Dept Ophthalmol, Milan, Italy
[2] Univ Eye Hosp, Dept Ophthalmol, Ulm, Germany
[3] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Novartis Pharma AG, Basel, Switzerland
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1122
引用
收藏
页码：S454 / S454
页数：1
相关论文
共 50 条
  • [1] LONG-TERM SAFETY AND EFFICACY OUTCOME OF RANIBIZUMAB 0.5 MG IN PATIENTS WITH VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR EDEMA: THE RESTORE EXTENSION STUDY
    Bailey, C.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2012, 22 (03) : 518 - 518
  • [2] Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
    Bandello, Francesco
    De Benedetto, Umberto
    Knutsson, Karl Anders
    Parodi, Maurizio Battaglia
    Cascavilla, Maria Lucia
    Iacono, Pierluigi
    [J]. CLINICAL OPHTHALMOLOGY, 2011, 5 : 1303 - 1308
  • [3] ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema
    Kodjikian, Laurent
    Lecleire-Collet, Amelie
    Dot, Corinne
    Le Lez, Marie-Laure
    Baillif, Stephanie
    Erginay, Ali
    Souied, Eric
    Fourmaux, Eric
    Gain, Philippe
    Ponthieux, Anne
    [J]. CLINICAL OPHTHALMOLOGY, 2021, 15 : 2307 - 2315
  • [4] Cardiovascular and cerebrovascular safety of ranibizumab 0.5 mg in diabetic macular edema
    Zarbin, Marco A.
    Ziemssen, Focke
    Margaron, Philippe
    Snow, Howard
    Dunger-Baldauf, Cornelia
    Hashmonay, Ron
    Bailey, Clare
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [5] Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study
    Xiaoxin Li
    Hong Dai
    Xiaorong Li
    Mei Han
    Jun Li
    Andrea Suhner
    Renxin Lin
    Sebastian Wolf
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 529 - 541
  • [6] Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study
    Li, Xiaoxin
    Dai, Hong
    Li, Xiaorong
    Han, Mei
    Li, Jun
    Suhner, Andrea
    Lin, Renxin
    Wolf, Sebastian
    Li, Xiaoxin
    Qi, Huijun
    Tao, Ye
    Li, Yan
    Bai, Yujing
    Yin, Hong
    Liu, Guodong
    Han, Li
    Qian, Tong
    Huang, Lvzhen
    Miao, Heng
    Zhao, Mingwei
    Hou, Jing
    Cheng, Yong
    Liang, Jianhong
    Shi, Xuan
    Qu, Jinfeng
    Yu, Wenzhen
    Tao, Yong
    Chen, Yi
    Zhang, Feng
    Shi, Xuehui
    Gao, Liqin
    Ding, Ning
    Yang, Lihong
    Zhao, Shiqiang
    Yang, Qiong
    Shen, Rong
    Xiong, Ying
    Dong, Fangtian
    Zhang, Xiao
    Gong, Di
    Qu, Yi
    Dai, Fangfang
    He, Feng
    Han, Xiaoxu
    Dai, Rongping
    Du, Hong
    Yu, Weihong
    Li, Donghui
    Yang, Zhikun
    Ma, Zhizhong
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (03) : 529 - 541
  • [7] Two-Year Safety and Efficacy of Ranibizumab 0.5 mg in Diabetic Macular Edema Interim Analysis of the RESTORE Extension Study
    Lang, Gabriele E.
    Berta, Andras
    Eldem, Bora M.
    Simader, Christian
    Sharp, Dianne
    Holz, Frank G.
    Sutter, Florian
    Gerstner, Ortrud
    Mitchell, Paul
    [J]. OPHTHALMOLOGY, 2013, 120 (10) : 2004 - 2012
  • [8] Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)
    Massin, Pascale
    Bandello, Francesco
    Garweg, Justus G.
    Hansen, Lutz L.
    Harding, Simon P.
    Larsen, Michael
    Mitchell, Paul
    Sharp, Dianne
    Wolf-Schnurrbusch, U. E. K.
    Gekkieva, Margarita
    Weichselberger, Andreas
    Wolf, Sebastian
    [J]. DIABETES CARE, 2010, 33 (11) : 2399 - 2405
  • [9] Safety Profile of Diabetic Macular Edema Patients Treated Over 12 Months With Ranibizumab in the RESOLVE Study
    Garcia-Arumi, J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [10] Impact of ranibizumab on visual impairment in patients with bilateral diabetic macular edema
    Fajnkuchen, Franck
    Pieramici, Dante
    Hrarat, Linda
    Best, Anne-Laurence
    Cohen, Salomon Y.
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Nghiem-Buffet, Sylvia
    Quentel, Gabriel
    Bodaghi, Bahram
    Giocanti-Auregan, Audrey
    [J]. ACTA DIABETOLOGICA, 2019, 56 (01) : 67 - 71
12345